Cancer Hospitals in Bangalore | Oncologists in Bangalore | Cancer Specialists in Bangalore

The diagnosis and treatment of cancer has undergone many changes in recent years. Early detection brought about by increased awareness and advanced diagnostic methods have ensured a high rate of survival. Find the list of our best cancer hospitals in Bangalore and top oncologists in Bangalore
KIDWAI Cancer Hospital Bangalore
KMIO is recognized as a charitable cancer institute in the Bangalore by the Endowment Department of Karnataka, considering its commitment for services to poor cancer patients.The charges levied for cancer investigations and treatment, are well within the reach of poor patients.In cases where the total treatment cost becomes too heavy, such patients are financially assisted by various schemes like Free drugs from the Institute, Karnataka Chief Minister’s Medical Relief fund, Poor Patients Welfare Fund, children Welfare Fund, Kidwai Cancer Drug Foundation, etc.The anti-cancer drugs sold at Kidwai Cancer Drug Foundation’ are 40 to 60% cheaper than the market rates.
HCG  – No 1 Oncology Hospital in Bangalore
Healthcare Global Enterprises Ltd HCG is India’s largest provider of cancer care. It recognized as best cancer hospital in Bangalore India with a network of 14 comprehensive cancer centres spread across India. HCG Bangalore has an integrated approach to cancer care delivery. Healthcare Global Enterprises (HCG) has grown rapidly and is currently a leader in cancer care, managing a network of 25 cancer centres that span Asia. Each centre is provided with a business system, management expertise and capital resources to bring patient focused, state-of-the art cancer care to new regions.
Manipal Global Hospitals – Best Cancer Hospital in Bangalore
At Manipal Hospitals, one of the top 5 cancer hospitals in Bangalore. The department of oncology recognizes and encourages the need for early detection. It provides a complete range of solutions for cancer care and to that end works in tandem with other super specialty departments for all round support and care under one roof. The department of Oncology has the latest amenities which help in correct and accurate diagnosis with the help of CT Scans, X-rays, blood tests, endoscopes, pap smears and biopsies. Cancer treatment is carried out by an expert team of oncologists who are among the finest cancer specialists in the country. Depending on the nature and stage, a wide range of therapies are used for the cancer treatment. Besides conventional cancer treatments like chemotherapy, radiotherapy and hormone therapy, the department of oncology also excels in the newer fields of nuclear medicine and stem cell transplants.
Apollo Hospitals – Oncology Specialists in Bangalore
Apollo Cancer Institute, Bangalore is a comprehensive, multi-modality state-of-art cancer care facility with a coordinated multidisciplinary approach. It has best top 5 oncologists in Bangalore. It brings in the latest technology and highly skilled health care professionals. This cancer institute has the unique advantage of being a stand-alone cancer unit having the most modern backup from all super specialty and diagnostic  support services including cytology, histopathology, hematology, pathology and radiology services including PET-CT, cath lab, physiotherapy, blood bank and many more.
Narayana Healthcare – Cancer Specialists in Bangalore
Narayana Health has advanced cancer diagnostic facility with MRI, CT, Mammogram, High Resolution Scanners and PET scan. Highly conformal radiotherapy units consisting of linear accelerators with IMRT, IGRT, V-Mat facilities are available. The Cancer Centre at Narayana Health has the expertise to handle cancers of Breast, Haemato, Gastrointestinal, Head and Neck, Gastroenterological, Gynaecological, Medical, Neurological, Paediatric, Thoracic and Urological.
Global Hospitals – Best Cancer Hospital in Bangalore
Global Hospitals is a reputed breast cancer hospital in Bangalore providing end-to-end cancer treatments. Global Hospital Rated as one of the best cancer hospital in Bangalore. In order to achieve this goal, the Institute provides a team of super specialists from different medical specialities who work together with the primary goal of Multi Super Speciality Organ Specific Cancer Care. Operated under the Global Cancer Institute (GCI) at Global Hospitals, The Department of Medical Oncology in Bangalore is one of the six methods to provide wholesome cancer care services that cover the range of diagnosis, treatment, disease management and rehabilitation.
Fortis Health Care – Best Oncologists in Bangalore
The Department of Oncology at Fortis Health Care has a comprehensive cancer care programme that follows trans-disciplinary and multi-modality approach in the field of adult and paediatric oncology. The department has an extensive medical programme, with super-sub-specialists in the field of Medical Oncology, Haematology  adult paediatric, Radiation Oncology, Specialised Onco surgery and Bone Marrow Transplant services. There are various specialised clinics and with a range of Support services for prevention, diagnosis and treatment of cancer. The focus of the cancer treatment has been on conservation of the involved organ as much as possible, without compromising on safety of the patient thereby ensuring faster recovery time, minimal or no disfiguration, and return to normal life at the earliest.
Sakra World Hospital – Top Oncologists in Bangalore
The Cancer and Blood Disorders Centre at Sakra World Hospital provides patients suffering from cancer and blood disorders such anaemia, low platelets, bleeding  clotting disorders, sickle cell disease, and thalassemia with the most advanced and effective treatments. Sakra’s Medical Oncology and Haematology team is headed by Dr. Vineet Gupta, an internationally recognized clinician in cancer care, having over a decade of experience in USA. At Sakra Cancer and Blood Disorders Centre, patients benefit by having a team of experts from various super-specialties working together to determine the best course of treatment, that is then delivered in a healing and compassionate environment.
Columbia Asia – Cancer Specialty Hospital in Bangalore
Columbia Asia Referral Hospital  Yeshwanthpur, Bangalore has a team of doctors who provide medical care for patients with solid organ tumors and blood related cancers. The consultants are highly qualified and have been trained at some of the best institutes in the world. The hospital provides the highest standards of care, where consultants practice evidence based medicine and follow international treatment protocols.The hospital offers screening and investigation for various cancers and also has a dedicated chemotherapy unit, a fully equipped blood bank and laboratory. The hospital has negative and positive pressure isolation rooms for patients and laminar flow for preparation of chemotherapy medications to reduce the risk of infection.
CyteCare Cancer Hospital – Cancer Care Hospital in Bangalore
Cytecare is led by a team of professionals with over 100+ persons and years of experience in leading healthcare and life sciences businesses globally, including Asia, Africa and in India. Recognizing the significant gap in quality of cancer care and use of standard, evidence-based protocols in cancer therapy in India, they saw the opportunity to bring in global best practices that is aimed at better clinical outcomes while also focusing on individual patient needs. Cytecare aims to revolutionize cancer treatment by providing personalized care through a network of cancer hospitals. The first hospital, a 150-bedded facility, is being launched in Yelahanka, Bengaluru.
Source:http://drshataz.com/tag/oncology-hospitals-in-bangalore/

Comments

Post a Comment

Popular posts from this blog

EMA validates Incyte’s MAA for retifanlimab to treat metastatic squamous cell anal carcinoma

Incyte, global biopharmaceutical company, announced the validation of the Company’s Marketing Authorization Application (MAA) for retifanlimab, an intravenous PD-1 inhibitor, as a potential treatment for adult patients with locally advanced or metastatic squamous cell anal carcinoma (SCAC) who have progressed on, or who are intolerant of, platinum-based chemotherapy. The European Medicines Agency’s (EMA) validation of the MAA confirms that the submission is sufficiently complete to begin the formal review process. “While the incidence of SCAC is increasing in Europe, treatment options for advanced disease are limited in their effectiveness, and there are no approved options once patients have progressed on standard therapy,” said Lance Leopold, M.D., Group vice president, Immuno-Oncology Clinical Development, Incyte. “The EMA validation of the MAA for retifanlimab – which follows the recent US Food & Drug Administration acceptance of our Biologics License Application for Priority R...
Read more

Tumour-targeting drug paves way for bone cancer treatment

 The treatment of osteosarcoma, the most common tumour of bone, is challenging, but a new study is offering hope to the patients with this disease. The study led by The University of  Texas MD Anderson Cancer Centre  found that a drug, known as bone metastasis-targeting peptidomimetic (BMTP-11), has potential as a new therapeutic strategy for this devastating illness. Results from the preclinical study looked at BMTP-11 alone and in combination with the chemotherapy agent gemcitabine. Although osteosarcoma is a relatively rare cancer, it is a leading disease-related cause of death in children and young adults ages 10 to 20. However, over the last 25 years, the five-year survival rate has remained unchanged, and the treatment options for these patients are few. In addition, the side effects of available treatment options often are significant and cumulative, and may cause other health problems and damage to major organs. "What's novel about this treatment is that...
Read more

Merck’s Keytruda plus platinum- and fluoropyrimidine-based chemotherapy receives US FDA nod to treat certain patients with locally advanced/metastatic esophageal or GEJ carcinoma

Merck, known as MSD outside the United States and Canada, announced that the US Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, for the treatment of patients with locally advanced or metastatic esophageal or gastroesophageal junction (GEJ) (tumors with epicenter 1 to 5 centimeters above the GEJ) carcinoma that is not amenable to surgical resection or definitive chemoradiation in combination with platinum- and fluoropyrimidine-based chemotherapy. The approval is based on results from the phase 3 KEYNOTE-590 trial, which demonstrated significant improvements in overall survival (OS), progression-free survival (PFS) and objective response rate (ORR) for Keytruda plus fluorouracil (FU) and cisplatin versus FU and cisplatin alone, regardless of histology or PD-L1 expression status. For OS and PFS, Keytruda plus FU and cisplatin reduced the risk of death by 27% (HR=0.73 [95% CI, 0.62-0.86]; p<0.0001) and reduced the risk of disease progression or death...
Read more